Mice

BS Benjamin J. Shields
JJ Jacob T. Jackson
DM Donald Metcalf
WS Wei Shi
QH Qiutong Huang
AG Alexandra L. Garnham
SG Stefan P. Glaser
DB Dominik Beck
JP John E. Pimanda
CB Clifford W. Bogue
GS Gordon K. Smyth
WA Warren S. Alexander
MM Matthew P. McCormack
request Request a Protocol
ask Ask a question
Favorite

All mice used were on a C57BL/6 background. The Hhexfl (Hunter et al. 2007), Hhex (Bogue et al. 2003), Mx-Cre (Kuhn et al. 1995), ROSA26-CreERT2 (Seibler et al. 2003), and Ink4a/Arf−/− (Serrano et al. 1996) mouse strains have been described. Four-week-old to 6-wk-old CD45.1+ C57BL/6 mice (Ly5.1; Walter and Eliza Hall Institute) were used as recipients in chimeric transplant experiments. To induce expression of the Mx1-Cre allele, polyinosinic–polycytidylic acid sodium salt [poly(I:C); Sigma] dissolved in saline was administered to mice (12 mg per kilogram of mouse body weight) intraperitoneally at 7 wk of age at least 3 wk prior to their use in experiments. To induce expression of the ROSA26-CreERT2 allele, mice were administered 70 µL of tamoxifen (4.2 mg [Sigma] in vehicle; 10% ethanol, 90% peanut oil [Sigma]) by oral gavage on two consecutive days, whereas placebo-treated mice received 70 µL of vehicle control. All experiments were approved by the Walter and Eliza Hall Institute Animal Ethics Committee.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A